Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

F. Perrone, M. De Laurentiis, S. De Placido, M. Orditura, S. Cinieri, F. Riccardi, A.S. Ribecco, C. Putzu, L. Del Mastro, E. Rossi, V. Tinessa, A.M. Mosconi, F. Nuzzo, F. Di Rella, A. Gravina, G. Iodice, G. Landi, C. Pacilio, V. Forestieri, R. LauriaA. Fabbri, T. Ibrahim, E. De Maio, S. Barni, S. Gori, V. Simeon, L. Arenare, G. Daniele, M.C. Piccirillo, N. Normanno, A. de Matteis, C. Gallo

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)178-186
Number of pages9
JournalEuropean Journal of Cancer
Volume118
DOIs
Publication statusPublished - 2019

Cite this